Objective： To compare the clinical effect of Chinese medicine （CM） and Western medicine （WM） for controlling the recurrence of pelvic endometriosis after a conservative operation. Methods： The study was a multi-...Objective： To compare the clinical effect of Chinese medicine （CM） and Western medicine （WM） for controlling the recurrence of pelvic endometriosis after a conservative operation. Methods： The study was a multi-center, randomized, parallel controlled and prospective clinical trial. Patients were randomly divided into two groups： CM group （106 cases） and WM group （102 cases）. Drugs were given to patients during 1--5 days of the first menstruation after a conservative operation in both groups. Patients with stages I and I1 （revised American Fertility Society） were treated for 3 months, while the patients with stages Ill and IV were treated for 6 months. The patients in the CM group were treated using three types of Chinese herbal medicine based on syndrome differentiation. Patients in the WM group were treated using gonadotropin releasing hormone agonist （GnRH-a） or gestrinone. Patients treated with GnRH-a received add-back therapy of Tibolone Tablets once a day after 4 months of treatment. Any cases of dysmenorrheal chronic pelvic pain, menstruation and any adverse reactions of patients were recorded once a month during the preoperative and postoperative periods and once every 3 months during the follow-up period. During the preoperative, postoperative and the follow-up periods, patients underwent type B ultrasonography of the pelvis and measurements of serum CA125 levels, gynecologic examination, routine evaluations of blood, urine, hepatic function （glutamate pyruvate transaminase）, renal function （blood urea nitrogen） and electrocardiograms. Dudng the follow-up period they underwent type B pelvic ultrasonography, measurement of serum CA125 levels and further gynecologic examinations. The two treatments were compared for clinical recurrence rates, pregnancy rates and the incidence of adverse reactions. Results： The incidence and timing of recurrence of endometriosis were not significantly different between the two groups. The first pregnancy achieved by the patient in the 展开更多
Objective： To investigate the effect of Chinese medicine （CM） and Western medicine （WM） on quality of life （QOL） after conservative surgery for endometriosis. Methods： A total of 320 patients with endometdosis...Objective： To investigate the effect of Chinese medicine （CM） and Western medicine （WM） on quality of life （QOL） after conservative surgery for endometriosis. Methods： A total of 320 patients with endometdosis were randomized into two groups by using random block design, CM group （160 cases, activating blood circulation and removing blood stasis treatment based on syndrome differentiation） and WM group （160 cases, gonadotropin-releasing hormone agonist or gestrinone treatment） after conservative surgery. Treatment was given for 3-6 months （according to the revised American Fertility Society scoring system stage）, and the Wodd Health Organization QOL-BREF （WHOQOL-BREF） was applied to patients before and after treatment to assess QOL. Results： There were 136 cases in the CM group and 141 cases in the WM group completing therapy. In the CM group, the use of the WHOQOL-BREF showed that the physical, psychological and environmental scores post- treatment were significantly higher than those at pre-treatment （P〈0.05）, and for 12 items （pain and discomfort, energy and fatigue, sleep and rest, mobility, activities of daily living, work capacity, negative feelings, health and social care： accessibility and quality, participation in and opportunities for recreation/leisure activities, appetite, QOL score, overall health status and QOL）, the difference in scores was significant （P〈0.05）. In the WM group, 4 items （pain and discomfort, opportunities for acquiring new information and skills, QOI_ score, overall health status and QOL） had significantly different scores post-treatment compared with those at pre-treatment （P〈0.05）. Before treatment, the QOL in the two groups of patients showed no significant difference （P〉0.05）. After treatment, the scores for physical health in the CM group were significantly higher than those of the WM group （P〈0.05） and the scores of 4 items （mobility, activities of daily living, sexual activity, QOL score） in the CM展开更多
基金Supported by the Key Projects of the National Science andTechnology Pillar Program during the 11th Five-Year PlanPeriod(No.2006BA104A)
文摘Objective： To compare the clinical effect of Chinese medicine （CM） and Western medicine （WM） for controlling the recurrence of pelvic endometriosis after a conservative operation. Methods： The study was a multi-center, randomized, parallel controlled and prospective clinical trial. Patients were randomly divided into two groups： CM group （106 cases） and WM group （102 cases）. Drugs were given to patients during 1--5 days of the first menstruation after a conservative operation in both groups. Patients with stages I and I1 （revised American Fertility Society） were treated for 3 months, while the patients with stages Ill and IV were treated for 6 months. The patients in the CM group were treated using three types of Chinese herbal medicine based on syndrome differentiation. Patients in the WM group were treated using gonadotropin releasing hormone agonist （GnRH-a） or gestrinone. Patients treated with GnRH-a received add-back therapy of Tibolone Tablets once a day after 4 months of treatment. Any cases of dysmenorrheal chronic pelvic pain, menstruation and any adverse reactions of patients were recorded once a month during the preoperative and postoperative periods and once every 3 months during the follow-up period. During the preoperative, postoperative and the follow-up periods, patients underwent type B ultrasonography of the pelvis and measurements of serum CA125 levels, gynecologic examination, routine evaluations of blood, urine, hepatic function （glutamate pyruvate transaminase）, renal function （blood urea nitrogen） and electrocardiograms. Dudng the follow-up period they underwent type B pelvic ultrasonography, measurement of serum CA125 levels and further gynecologic examinations. The two treatments were compared for clinical recurrence rates, pregnancy rates and the incidence of adverse reactions. Results： The incidence and timing of recurrence of endometriosis were not significantly different between the two groups. The first pregnancy achieved by the patient in the
基金Supported by the "Eleventh-Five" National Technology Support Program Project(No.2006BAI04A17)
文摘Objective： To investigate the effect of Chinese medicine （CM） and Western medicine （WM） on quality of life （QOL） after conservative surgery for endometriosis. Methods： A total of 320 patients with endometdosis were randomized into two groups by using random block design, CM group （160 cases, activating blood circulation and removing blood stasis treatment based on syndrome differentiation） and WM group （160 cases, gonadotropin-releasing hormone agonist or gestrinone treatment） after conservative surgery. Treatment was given for 3-6 months （according to the revised American Fertility Society scoring system stage）, and the Wodd Health Organization QOL-BREF （WHOQOL-BREF） was applied to patients before and after treatment to assess QOL. Results： There were 136 cases in the CM group and 141 cases in the WM group completing therapy. In the CM group, the use of the WHOQOL-BREF showed that the physical, psychological and environmental scores post- treatment were significantly higher than those at pre-treatment （P〈0.05）, and for 12 items （pain and discomfort, energy and fatigue, sleep and rest, mobility, activities of daily living, work capacity, negative feelings, health and social care： accessibility and quality, participation in and opportunities for recreation/leisure activities, appetite, QOL score, overall health status and QOL）, the difference in scores was significant （P〈0.05）. In the WM group, 4 items （pain and discomfort, opportunities for acquiring new information and skills, QOI_ score, overall health status and QOL） had significantly different scores post-treatment compared with those at pre-treatment （P〈0.05）. Before treatment, the QOL in the two groups of patients showed no significant difference （P〉0.05）. After treatment, the scores for physical health in the CM group were significantly higher than those of the WM group （P〈0.05） and the scores of 4 items （mobility, activities of daily living, sexual activity, QOL score） in the CM
